tiprankstipranks

Kenneth Bate Insider Profile

4 Followers
Kenneth Bate, Director at BioMarin Pharmaceutical, holds 1.20K shares in Madrigal Pharmaceuticals (Ticker: MDGL), holds 375.00 shares in AVEO Pharma (Ticker: AVEO), holds 0.00 shares in Epizyme (Ticker: EPZM).
tipranks
Kenneth Bate

Kenneth Bate
BioMarin Pharmaceutical (BMRN)
Director

Not Ranked
Kenneth Bate has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
80.58%
19.42%
0.00%
0.00%
0.00% Others
A breakdown of Kenneth Bate's holdings

Insider Roles

BioMarin Pharmaceutical
(BMRN)
Director
Madrigal Pharmaceuticals
(MDGL)
Director
Vanda
(VNDA)
Director
Astria Therapeutics
(ATXS)
Director
+1 other positions
Roles that Kenneth Bate holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Kenneth Bate

Kenneth Bate's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
BioMarin Pharmaceutical
Jun 18, 2015
Director
Uninformative Buy
$960.81K
Vanda
Jun 19, 2017
Director
Uninformative Buy
$0.00
Madrigal Pharmaceuticals
Apr 03, 2024
Director
Uninformative Sell
8.21M
$231.61K
Astria Therapeutics
Director
AVEO
AVEO Pharma
Jan 19, 2023
Uninformative Sell
5.63K
$5.63K
CBST
Cubist Pharma
Jan 21, 2015
Uninformative Sell
980.73K
EPZM
Epizyme
Aug 16, 2022
Uninformative Sell
$0.00
Genocea Biosciences
Director
$0.00
List of latest transactions for each holding click on a transaction to see Kenneth Bate's performance on stock

Kenneth Bate insider profile FAQ

What is the percentage of profitable transactions made by Kenneth Bate?
The percentage of profitable transactions made by Kenneth Bate is ―.
    What is the average return per transaction made by Kenneth Bate?
    The average return per transaction made by Kenneth Bate is ―.
      What stocks does Kenneth Bate hold?
      Kenneth Bate holds: BMRN, VNDA, MDGL, ATXS, AVEO, CBST, EPZM, GNCAQ stocks.
        What was Kenneth Bate’s latest transaction?
        Kenneth Bate latest transaction was an Uninformative Sell of $8.21M.
          What was Kenneth Bate's most profitable transaction?
          Kenneth Bate’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Kenneth Bate's role in BioMarin Pharmaceutical?
            Kenneth Bate's role in BioMarin Pharmaceutical is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.